scholarly journals Neratinib in adjuvant treatment of patients with HER2-positive breast cancer — less is more?

2019 ◽  
Vol 15 (2) ◽  
pp. 111-114
Author(s):  
Ewa Cedrych ◽  
Ida Cedrych
Keyword(s):  
Breast Cancer ◽  
Adjuvant Treatment ◽  
Her2 Positive ◽  
Less Is More ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?

2020 ◽  
Vol 20 (6) ◽  
pp. 503-510
Author(s):  
Haiping Lin ◽  
Hongjuan Zheng ◽  
Chenyang Ge ◽  
Qinghua Wang ◽  
Wanfen Tang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Treatment ◽  
Her2 Positive ◽  
Node Negative ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study

2017 ◽  
Vol 74 ◽  
pp. 47-54 ◽  
Author(s):  
Mette S. van Ramshorst ◽  
Erik van Werkhoven ◽  
Ingrid A.M. Mandjes ◽  
Margaret Schot ◽  
Jelle Wesseling ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Treatment ◽  
Weekly Paclitaxel ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer

2020 ◽  
Vol 3 (11) ◽  
pp. e2027074
Author(s):  
Natalia Kunst ◽  
Shi-Yi Wang ◽  
Annette Hood ◽  
Sarah S. Mougalian ◽  
Michael P. DiGiovanna ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Adjuvant Treatment ◽  
Treatment Strategies ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document